Original language | English |
---|---|
Pages (from-to) | 816-818 |
Number of pages | 3 |
Journal | Diabetes Technology and Therapeutics |
Volume | 16 |
Issue number | 11 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations
OpT2mise Study Group
- Université de Caen
- Medtronic
- University Clinic of Endocrinology
- Peterfy Hospital
- Clinical Center of Serbia
- ERS Endocrine Research Inc.
- Sheba Medical Center at Tel Hashomer
- Connect Health Centre
- Diabetes Clinic
- Health Science Center
- Greenacres Hospital
- Canadian Centre for Research on Diabetes
- LMC Endocrinology Centres (Thornhill) Ltd.
- Toronto General Hospital
- Bethesda Diabetes Research Center
- Fachklinik Bad Heilbrunn
- CHU de Nancy
- Atlanta Diabetes Associates
- Albany Medical College
- Assaf Harofeh Medical Center
- Soroka Medical Center
- University of Calgary
- University of Rome La Sapienza
- McGill University
- Hospital Clinic Barcelona
- Centre for Diabetes and Endocrinology
- SUNY Upstate Medical University
- Rabin Medical Center Israel
- City Hospital Vienna
- Hadassah University Medical Centre
- Diabetes Research Institute
- University of Bari
- IJsselland Ziekenhuis
- Maxima Medical Centre
- Université de Strasbourg
- CHU de Toulouse
- University of Perugia
Research output: Contribution to journal › Letter › peer-review
10
Scopus
citations